4.5 Article

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

期刊

ANAESTHESIA
卷 76, 期 6, 页码 748-758

出版社

WILEY
DOI: 10.1111/anae.15458

关键词

COVID-19; delay; SARS-CoV-2; surgery; timing

资金

  1. RCS Covid Research Group
  2. National Institute for Health Research (NIHR) Global Health Research Unit
  3. Association of Coloproctology of Great Britain and Ireland
  4. Bowel and Cancer Research
  5. Bowel Disease Research Foundation
  6. Association of Upper Gastrointestinal Surgeons
  7. British Association of Surgical Oncology
  8. British Gynaecological Cancer Society
  9. European Society of Coloproctology
  10. Medtronic
  11. NIHR Academy
  12. Sarcoma UK
  13. Urology Foundation
  14. Vascular Society for Great Britain and Ireland
  15. Yorkshire Cancer Research
  16. National Institute for Health Research [NIHR300175] Funding Source: researchfish

向作者/读者索取更多资源

The study suggests that surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection, with patients experiencing ongoing symptoms >= 7 weeks from diagnosis potentially benefitting from further delay.
Peri-operative SARS-CoV-2 infection increases postoperative mortality. The aim of this study was to determine the optimal duration of planned delay before surgery in patients who have had SARS-CoV-2 infection. This international, multicentre, prospective cohort study included patients undergoing elective or emergency surgery during October 2020. Surgical patients with pre-operative SARS-CoV-2 infection were compared with those without previous SARS-CoV-2 infection. The primary outcome measure was 30-day postoperative mortality. Logistic regression models were used to calculate adjusted 30-day mortality rates stratified by time from diagnosis of SARS-CoV-2 infection to surgery. Among 140,231 patients (116 countries), 3127 patients (2.2%) had a pre-operative SARS-CoV-2 diagnosis. Adjusted 30-day mortality in patients without SARS-CoV-2 infection was 1.5% (95%CI 1.4-1.5). In patients with a pre-operative SARS-CoV-2 diagnosis, mortality was increased in patients having surgery within 0-2 weeks, 3-4 weeks and 5-6 weeks of the diagnosis (odds ratio (95%CI) 4.1% (3.3-4.8), 3.9% (2.6-5.1) and 3.6% (2.0-5.2), respectively). Surgery performed >= 7 weeks after SARS-CoV-2 diagnosis was associated with a similar mortality risk to baseline (odds ratio (95%CI) 1.5% (0.9-2.1%)). After a >= 7 week delay in undertaking surgery following SARS-CoV-2 infection, patients with ongoing symptoms had a higher mortality than patients whose symptoms had resolved or who had been asymptomatic (6.0% (95%CI 3.2-8.7) vs. 2.4% (95%CI 1.4-3.4) vs. 1.3% (95%CI 0.6-2.0%), respectively). Where possible, surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection. Patients with ongoing symptoms >= 7 weeks from diagnosis may benefit from further delay.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据